In his most intimate performances in years, Jay-Z will headline at Carnegie Hall, in Stern Auditorium/Perelman Stage, raising money for United Way of New York City and the Shawn Carter Scholarship Foundation on February 6, 2012 at 8:00 p.m. and February 7, 2012 at 9:30 p.m.

Jay Z Carnegie Hall
Jay Z Carnegie Hall

Tickets will go on sale to the public on Monday, January 30 at 11:00 a.m. EST. Concert goers will get a once in a lifetime experience as Jay-Z takes the stage at the New York landmark to raise dollars that will help fight poverty, boost on-time graduation rates in underserved New York City schools, and put college within reach for low-income students across the five boroughs.

Tickets will be available on Monday, January 30 at 11:00 AM EST at www.carnegiehall.org, CarnegieCharge: 212-247-7800, or at Carnegie Hall’s Box Office at 57th Street and Seventh Avenue. VIP ticket packages that offer exclusive access to pre- and post-events are also available during the public ticket sale. For information on sponsorship opportunities or VIP tickets, please contact jayzconcerts@uwnyc.org.

Poverty has the strongest correlation to dropout rates. New York City has the largest income gap in the U.S., and thirty percent of children in New York City live in poverty. Because of statistics like these, coupled with the fact that thirty-nine percent of New York City students who enter high school will not graduate on time, United Way of New York City, The Shawn Carter Scholarship Foundation and Shawn “Jay-Z” Carter are coming together to get children and youth the education they deserve and to put higher education within reach.

comments powered by Disqus

Latest news

Cool Comedy • Hot Cuisine Raises Over $1.3 Million for Scleroderma Research Foundation

Cool Comedy • Hot Cuisine Raises Over $1.3 Million for Scleroderma Research Foundation Nov 5, 2024

Last week, in a special evening honoring John Mayer and Jeff Ross, Cool Comedy • Hot Cuisine raised more than $1.3 million for the Scleroderma Research Foundation (SRF)—the country’s first and leading nonprofit investor in medical research into scleroderma. More
More news